Communiqués Glycorex Transplantation AB

Actions

GTAB B

SE0000524530

Recherche biotechnologique et médicale

Cours en clôture NORDIC GROWTH MARKET 02/10/2026			Varia. 5j.	Varia. 1 janv.
1,565 ^SEK	+3,99%		+28,28%	-1,57%

30/09	Glycorex Transplantation AB annonce les résultats de l’étude Glycosorb ABO démontrant la production efficace de plaquettes universelles	CI
08/09	Glycorex Transplantation signe un accord de distribution pour Glycosorb ABO au Brésil	MT

Communiqués

30/09	Glycorex Transplantation (GTAB B): Glycorex Technology Validated in Transfusion - New Study Demonstrates Effective Production of Universal Platelets	AQ
07/09	Glycorex Transplantation (GTAB B): enters into a distribution agreement in Brazil for Glycosorb® ABO	AQ
27/08	Glycorex Transplantation (GTAB B): Signs distribution agreement in Malaysia for Glycosorb® ABO	AQ
06/08	Glycorex Transplantation (GTAB B): Signs distribution agreement in Argentina for Glycosorb® ABO	AQ
25/02	Glycorex Transplantation : Year end report 2025 (Glycorex Year end report 2025)	PU
06/02	JHLT-recognised ABO-incompatible paediatric transplant study	AQ
05/12	Glycorex Transplantation : Interim Report Quarter 3 (Glycorex Interim report Q3)	PU
13/08/25	Glycorex Transplantation (GTAB B): First ABO-incompatible organ transplantion in Morocco with Glycosorb® ABO	AQ
25/06/25	Glycorex Transplantation : Annual Report 2024	PU
28/02/25	Glycorex Transplantation (GTAB B): Enters distribution agreement in Greece for Glycosorb® ABO in the field of transfusion and transplantation	AQ
27/02/25	Glycorex Transplantation : Year End Report 2024	PU
18/02/25	Glycorex Transplantation AB: First ABO-incompatible transplantation in Portugal with Glycosorb® ABO	AQ
23/12/24	Glycorex Transplantation AB (GTAB B): First blood group-incompatible pediatric heart transplantation in Austria using Glycosorb® ABO	AQ
13/09/24	Glycorex Transplantation AB (GTAB B): Results from Norwegian platelet evaluation presented at conference	AQ
13/08/24	Glycorex Transplantation AB: First ABO-incompatible transplantation in Argentina with Glycosorb® ABO	AQ
13/05/24	Glycosorb® ABO is pushing the boundaries in paediatric blood group incompatible heart transplantation	AQ
08/05/24	First publication from South Africa and first stem cell transplantation performed in Mexico	AQ
20/02/24	Glycorex Transplantation (GTAB B): Signs agreement with distributor in Romania	AQ
29/11/23	Glycorex Transplantation AB: Entering into an agreement with Bio-Rad Laboratories, Inc.	AQ
29/11/23	Glycorex Transplantation AB (publ): Interim Report January - September 2023	AQ
30/08/23	Glycorex Transplantation AB (publ): Interim Report January - June 2023	AQ
24/05/23	Glycorex Transplantation AB (publ): Interim Report January - March 2023	AQ
28/04/23	Annual Report 2022 Glycorex Transplantation AB (publ)	AQ
09/03/23	Published study from the US shows promising results on the use of Glycosorb® ABO to provide low-titer group O whole blood	AQ
20/02/23	The first blood group incompatible kidney transplant using Glycosorb® ABO performed in South Africa	AQ